【4577】ダイト

医薬品の原薬の製造販売。ジェネリックメーカー向けが多い。

東証プライム

医薬品医薬

＞

ジェネリックメーカージェ

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2024.05	2024/04/12	修正予	47,500	→	0.0%	0.0%	4,800	→	0.0%	0.0%	4,800	→	0.0%	0.0%	3,300	→	0.0%	0.0%
2024.05	2024/01/12	Q2予	47,500	→	0.0%	0.0%	4,800	→	0.0%	0.0%	4,800	→	0.0%	0.0%	3,300	→	0.0%	0.0%
2024.05	2023/10/12	Q1予	47,500	→	0.0%	0.0%	4,800	→	0.0%	0.0%	4,800	→	0.0%	0.0%	3,300	→	0.0%	0.0%
2024.05	2023/07/14	当初予	47,500	-	-	-	4,800	-	-	-	4,800	-	-	-	3,300	-	-	-
2023.05	2023/07/14	実	45,101	↑	+2.5%	+2.5%	5,207	↑	+15.7%	+15.7%	5,169	↑	+12.4%	+12.4%	3,600	↑	+12.5%	+12.5%
2023.05	2023/04/13	Q3予	44,000	→	0.0%	0.0%	4,500	→	0.0%	0.0%	4,600	→	0.0%	0.0%	3,200	→	0.0%	0.0%
2023.05	2023/01/13	Q2予	44,000	→	0.0%	0.0%	4,500	→	0.0%	0.0%	4,600	→	0.0%	0.0%	3,200	→	0.0%	0.0%
2023.05	2022/10/13	Q1予	44,000	→	0.0%	0.0%	4,500	→	0.0%	0.0%	4,600	→	0.0%	0.0%	3,200	→	0.0%	0.0%
2023.05	2022/07/14	当初予	44,000	-	-	-	4,500	-	-	-	4,600	-	-	-	3,200	-	-	-
2022.05	2022/07/14	実	43,464	↑	+2.3%	+2.3%	6,553	↑	+11.1%	+11.1%	6,729	↑	+12.1%	+12.1%	4,668	↑	+9.8%	+9.8%
2022.05	2022/04/14	Q3予	42,500	→	0.0%	0.0%	5,900	→	0.0%	0.0%	6,000	→	0.0%	0.0%	4,250	→	0.0%	0.0%
2022.05	2022/01/14	Q2予	42,500	→	0.0%	0.0%	5,900	→	0.0%	0.0%	6,000	→	0.0%	0.0%	4,250	→	0.0%	0.0%
2022.05	2021/10/13	Q1予	42,500	→	0.0%	0.0%	5,900	→	0.0%	0.0%	6,000	→	0.0%	0.0%	4,250	→	0.0%	0.0%
2022.05	2021/07/14	当初予	42,500	-	-	-	5,900	-	-	-	6,000	-	-	-	4,250	-	-	-
2021.05	2021/07/14	実	48,714	↓	-0.4%	+2.6%	5,908	↑	+0.1%	+19.4%	6,067	↑	+1.1%	+21.3%	4,246	↑	+6.2%	+24.9%
2021.05	2021/04/14	Q3予	48,900	↑	+2.9%	+2.9%	5,900	↑	+19.2%	+19.2%	6,000	↑	+20.0%	+20.0%	4,000	↑	+17.6%	+17.6%
2021.05	2021/01/14	Q2予	47,500	→	0.0%	0.0%	4,950	→	0.0%	0.0%	5,000	→	0.0%	0.0%	3,400	→	0.0%	0.0%
2021.05	2020/10/13	Q1予	47,500	→	0.0%	0.0%	4,950	→	0.0%	0.0%	5,000	→	0.0%	0.0%	3,400	→	0.0%	0.0%
2021.05	2020/07/10	当初予	47,500	-	-	-	4,950	-	-	-	5,000	-	-	-	3,400	-	-	-
2020.05	2020/07/10	実	44,991	↑	+3.4%	+3.4%	5,357	↑	+14.0%	+14.0%	5,462	↑	+15.0%	+15.0%	3,944	↑	+19.5%	+19.5%
2020.05	2020/04/14	Q3予	43,500	→	0.0%	0.0%	4,700	→	0.0%	0.0%	4,750	→	0.0%	0.0%	3,300	→	0.0%	0.0%
2020.05	2020/01/14	Q2予	43,500	→	0.0%	0.0%	4,700	→	0.0%	0.0%	4,750	→	0.0%	0.0%	3,300	→	0.0%	0.0%
2020.05	2019/10/11	Q1予	43,500	→	0.0%	0.0%	4,700	→	0.0%	0.0%	4,750	→	0.0%	0.0%	3,300	→	0.0%	0.0%
2020.05	2019/07/12	当初予	43,500	-	-	-	4,700	-	-	-	4,750	-	-	-	3,300	-	-	-
2019.05	2019/07/12	実	41,134	↑	+0.8%	+0.8%	4,547	↑	+5.7%	+5.7%	4,641	↑	+6.7%	+6.7%	3,513	↑	+13.3%	+13.3%
2019.05	2019/04/12	Q3予	40,800	→	0.0%	0.0%	4,300	→	0.0%	0.0%	4,350	→	0.0%	0.0%	3,100	→	0.0%	0.0%
2019.05	2019/01/11	Q2予	40,800	→	0.0%	0.0%	4,300	→	0.0%	0.0%	4,350	→	0.0%	0.0%	3,100	→	0.0%	0.0%
2019.05	2018/10/11	Q1予	40,800	→	0.0%	0.0%	4,300	→	0.0%	0.0%	4,350	→	0.0%	0.0%	3,100	→	0.0%	0.0%
2019.05	2018/07/13	当初予	40,800	-	-	-	4,300	-	-	-	4,350	-	-	-	3,100	-	-	-
2018.05	2018/07/13	実	39,875	↑	+0.9%	-1.5%	4,161	↑	+1.5%	+1.5%	4,244	↑	+2.3%	+2.3%	3,041	↑	+6.7%	+6.7%
2018.05	2018/04/13	Q3予	39,500	↓	-2.5%	-2.5%	-	-	-	-	4,150	→	0.0%	0.0%	2,850	→	0.0%	0.0%
2018.05	2018/01/12	Q2予	40,500	→	0.0%	0.0%	4,100	→	0.0%	0.0%	4,150	→	0.0%	0.0%	2,850	→	0.0%	0.0%
2018.05	2017/10/11	Q1予	40,500	→	0.0%	0.0%	4,100	→	0.0%	0.0%	4,150	→	0.0%	0.0%	2,850	→	0.0%	0.0%
2018.05	2017/07/11	当初予	40,500	-	-	-	4,100	-	-	-	4,150	-	-	-	2,850	-	-	-
2017.05	2017/07/11	実	37,984	↓	-0.3%	-0.3%	3,832	↑	+3.6%	+3.6%	3,878	↑	+3.4%	+3.4%	2,656	↑	+2.2%	+2.2%
2017.05	2017/04/14	Q3予	38,100	→	0.0%	0.0%	3,700	→	0.0%	0.0%	3,750	→	0.0%	0.0%	2,600	→	0.0%	0.0%
2017.05	2017/01/13	Q2予	38,100	→	0.0%	0.0%	3,700	→	0.0%	0.0%	3,750	→	0.0%	0.0%	2,600	→	0.0%	0.0%
2017.05	2016/10/12	当初予	38,100	-	-	-	3,700	-	-	-	3,750	-	-	-	2,600	-	-	-
2016.05	2016/07/12	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2016.05	2016/04/12	Q3予	37,000	→	0.0%	0.0%	3,550	→	0.0%	0.0%	3,500	→	0.0%	0.0%	2,300	→	0.0%	0.0%
2016.05	2016/01/08	Q2予	37,000	→	0.0%	0.0%	3,550	→	0.0%	0.0%	3,500	→	0.0%	0.0%	2,300	→	0.0%	0.0%
2016.05	2015/10/08	Q1予	37,000	→	0.0%	0.0%	3,550	→	0.0%	0.0%	3,500	→	0.0%	0.0%	2,300	→	0.0%	0.0%
2016.05	2015/07/10	当初予	37,000	-	-	-	3,550	-	-	-	3,500	-	-	-	2,300	-	-	-
2015.05	2015/07/10	実	34,058	↓	-1.3%	-1.3%	3,518	↑	+2.0%	+2.0%	3,452	↑	+0.1%	+0.1%	2,246	↑	+2.1%	+2.1%
2015.05	2015/04/10	Q3予	34,500	→	0.0%	0.0%	3,450	→	0.0%	0.0%	3,450	→	0.0%	0.0%	2,200	→	0.0%	0.0%
2015.05	2015/01/09	Q2予	34,500	→	0.0%	0.0%	3,450	→	0.0%	0.0%	3,450	→	0.0%	0.0%	2,200	→	0.0%	0.0%
2015.05	2014/10/10	Q1予	34,500	→	0.0%	0.0%	3,450	→	0.0%	0.0%	3,450	→	0.0%	0.0%	2,200	→	0.0%	0.0%
2015.05	2014/07/10	当初予	34,500	-	-	-	3,450	-	-	-	3,450	-	-	-	2,200	-	-	-
2014.05	2014/07/10	実	31,196	-	-	-	2,938	-	-	-	2,920	-	-	-	1,811	-	-	-

【4577】ダイト 医薬品の原薬の製造販売。ジェネリックメーカー向けが多い。

業績予想修正履歴

【4577】ダイト

医薬品の原薬の製造販売。ジェネリックメーカー向けが多い。